Literature DB >> 10547160

Adenovirus vector expressing mouse oncostatin M induces acute-phase proteins and TIMP-1 expression in vivo in mice.

C Kerr1, C Langdon, F Graham, J Gauldie, T Hara, C D Richards.   

Abstract

Mouse oncostatin M (MuOSM) regulates the production of acute-phase proteins by hepatocytes as well as tissue inhibitor of metalloproteinases-1 (TIMP-1) production by fibroblasts in vitro. We have generated an adenovirus (Ad) encoding MuOSM and tested the effects of administration of recombinant AdMuOSM to mice in vivo. On intramuscular injection, AdMuOSM (5 X 10(7) plaque-forming units, pfu) induced an increase in serum levels of interleukin-6 (IL-6) as well as the acute-phase proteins serum amyloid A (SAP) and alpha1-acid glycoprotein (AGP) at day 1. SAP and AGP concentrations were elevated to greater levels at day 3 and decreased to near control levels at day 7. Intratracheal treatment with AdMuOSM induced TIMP-1 mRNA levels (as assessed by Northern blots) that corresponded to the presence of transgene MuOSM mRNA levels. TIMP-1 was elevated at day 1 and day 3 and less consistently at day 7 after administration. Intraperitoneal treatment with AdMuOSM also resulted in elevation of TIMP-1 mRNA in lung tissue. These results show that AdMuOSM can induce both local and systemic effects and demonstrate in vivo effects of OSM that are consistent with in vitro studies on acute-phase protein and TIMP-1 expression.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10547160     DOI: 10.1089/107999099313145

Source DB:  PubMed          Journal:  J Interferon Cytokine Res        ISSN: 1079-9907            Impact factor:   2.607


  6 in total

1.  Murine oncostatin M stimulates mouse synovial fibroblasts in vitro and induces inflammation and destruction in mouse joints in vivo.

Authors:  C Langdon; C Kerr; M Hassen; T Hara; A L Arsenault; C D Richards
Journal:  Am J Pathol       Date:  2000-10       Impact factor: 4.307

2.  Adenoviral transfer of murine oncostatin M elicits periosteal bone apposition in knee joints of mice, despite synovial inflammation and up-regulated expression of interleukin-6 and receptor activator of nuclear factor-kappa B ligand.

Authors:  Alfons S K de Hooge; Fons A J van de Loo; Miranda B Bennink; Diana S de Jong; Onno J Arntz; Erik Lubberts; Carl D Richards; Wim B vandDen Berg
Journal:  Am J Pathol       Date:  2002-05       Impact factor: 4.307

3.  Inhibition of Janus kinase/signal transducer and activator of transcription (JAK/STAT) signalling pathway in rheumatoid synovial fibroblasts using small molecule compounds.

Authors:  K Migita; Y Izumi; T Torigoshi; K Satomura; M Izumi; Y Nishino; Y Jiuchi; M Nakamura; H Kozuru; F Nonaka; K Eguchi; A Kawakami; S Motokawa
Journal:  Clin Exp Immunol       Date:  2013-12       Impact factor: 4.330

4.  Adenoviral gene transfer of interleukin-1 in combination with oncostatin M induces significant joint damage in a murine model.

Authors:  Andrew D Rowan; Wang Hui; Tim E Cawston; Carl D Richards
Journal:  Am J Pathol       Date:  2003-06       Impact factor: 4.307

5.  Oncostatin M gene therapy attenuates liver damage induced by dimethylnitrosamine in rats.

Authors:  Tetsuhiro Hamada; Ayuko Sato; Tadamichi Hirano; Takashi Yamamoto; Gakuhei Son; Masayuki Onodera; Ikuko Torii; Takashi Nishigami; Minoru Tanaka; Atsushi Miyajima; Shuhei Nishiguchi; Jiro Fujimoto; Tohru Tsujimura
Journal:  Am J Pathol       Date:  2007-07-19       Impact factor: 4.307

6.  Overexpression of OSM and IL-6 impacts the polarization of pro-fibrotic macrophages and the development of bleomycin-induced lung fibrosis.

Authors:  Ehab A Ayaub; Anisha Dubey; Jewel Imani; Fernando Botelho; Martin R J Kolb; Carl D Richards; Kjetil Ask
Journal:  Sci Rep       Date:  2017-10-16       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.